Data-driven subgroups of newly diagnosed type 2 diabetes and the relationship with cardiovascular diseases at genetic and clinical levels in Chinese adults.

[1]  Li Zheng,et al.  Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose , 2023, Clinical pharmacology and therapeutics.

[2]  Wenying Yang,et al.  Higher mitochondrial DNA copy number is associated with metformin-induced weight loss , 2023, Communications Medicine.

[3]  M. Udler,et al.  Phenotypic and genetic classification of diabetes , 2022, Diabetologia.

[4]  M. Wenk,et al.  Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes , 2022, Diabetologia.

[5]  Mingqun Deng,et al.  Application of novel subgroups of Chinese inpatients with diabetes based on machine learning paradigm. , 2022, Diabetes & metabolic syndrome.

[6]  L. Groop,et al.  Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications , 2022, Diabetes care.

[7]  A. Hattersley,et al.  Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes , 2022, Nature Medicine.

[8]  F. Pattou,et al.  Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study. , 2022, The lancet. Diabetes & endocrinology.

[9]  Alexander E. Lopez,et al.  Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes , 2021, Nature Genetics.

[10]  Alicia R. Martin,et al.  Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps , 2021, Nature Medicine.

[11]  J. Knowles,et al.  Genetics of Type 2 Diabetes: Opportunities for Precision Medicine: JACC Focus Seminar. , 2021, Journal of the American College of Cardiology.

[12]  F. Kronenberg,et al.  Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals , 2021, Journal of internal medicine.

[13]  J. Danesh,et al.  Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.

[14]  Lixin Guo,et al.  Application of new international classification of adult‐onset diabetes in Chinese inpatients with diabetes mellitus , 2020, Diabetes/metabolism research and reviews.

[15]  J. Bressler,et al.  Mitochondrial DNA copy number can influence mortality and cardiovascular disease via methylation of nuclear DNA CpGs , 2020, Genome medicine.

[16]  Xilin Yang,et al.  Validation of the Swedish diabetes regrouping scheme in adult-onset diabetes in China. , 2020, The Journal of clinical endocrinology and metabolism.

[17]  D. Arking,et al.  Blood-derived mitochondrial DNA copy number is associated with gene expression across multiple tissues and is predictive for incident neurodegenerative disease , 2020, bioRxiv.

[18]  E. Vassos,et al.  Polygenic risk scores: from research tools to clinical instruments , 2020, Genome Medicine.

[19]  J. Florez,et al.  Genetics of diabetes mellitus and diabetes complications , 2020, Nature Reviews Nephrology.

[20]  L. Groop,et al.  Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. , 2019, The lancet. Diabetes & endocrinology.

[21]  Cassandra N. Spracklen,et al.  Identification of type 2 diabetes loci in 433,540 East Asian individuals , 2019, bioRxiv.

[22]  Gad Getz,et al.  Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis , 2018, PLoS medicine.

[23]  E. Topol,et al.  The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.

[24]  L. Groop,et al.  Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. , 2018, The lancet. Diabetes & endocrinology.

[25]  Brent S. Pedersen,et al.  Mosdepth: quick coverage calculation for genomes and exomes , 2017, bioRxiv.

[26]  E. Boerwinkle,et al.  Association between Mitochondrial DNA Copy Number in Peripheral Blood and Incident CKD in the Atherosclerosis Risk in Communities Study. , 2016, Journal of the American Society of Nephrology : JASN.

[27]  T. Yang,et al.  Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the CONFIDENCE study) , 2015, Journal of internal medicine.

[28]  Ernesto Picardi,et al.  MToolBox: a highly automated pipeline for heteroplasmy annotation and prioritization analysis of human mitochondrial variants in high-throughput sequencing , 2014, Bioinform..

[29]  Dong Zhao,et al.  Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. , 2004, JAMA.

[30]  Zhanxing Zhu,et al.  Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. , 2019, The lancet. Diabetes & endocrinology.

[31]  Wenying Yang,et al.  Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. , 2014, The lancet. Diabetes & endocrinology.